The South and Central Americamedical headwalls market is expected to reach US$ 60.21 million in 2027 from US$ 46.15 million in 2019. The market is estimated to grow with a CAGR of 3.9% from 2020-2027.
The market growth is attributed to the factors such as the rising burden of chronic diseases and increased investment by the private sector in hospitals. However, the high cost of healthcare facilities in low and middle-income countries is limiting the market growth.
The medical headwalls system, an architectural structure in patient wards, combines electrical and medical gas functions along with aiding efficient handling of cords and tubing. The hospital headwalls decrease clutter caused by cords and tubing, provide healthcare staff an easy access to the patient care accessories, and enhance the esthetics of the room. The reduction of a visual clutter also creates a safer and more operative environment that allows medical professionals to work freely.
Chronic diseases and the associated risk factors are the significant causes of death, disability, and illness in the South and Central America region. Cardiovascular diseases (CVDs) are the primary cause of disability and death in Brazil and Argentina, and they were responsible for ~35% of all deaths and 68% of the total disease burden in 2004. In contrast, infectious diseases such as tuberculosis, malaria, and HIV/AIDS account for 10% of deaths. The Cardiovascular Risk Factor Multiple Evaluation (CARMELA) study, is a population-based study in seven major Latin American urban areas, has anticipated the prevalence of obesity at 23% and that of smoking at 30% of the population with age >25. This puts the region at the high end of obesity figures in the Organization for Economic Cooperation and Development (OECD) countries. Moreover, according to the World Bank, the occurrence of chronic diseases has steadily increased across South and Central America due to an unhealthy lifestyle (i.e., inadequate diet, physical inactivity, tobacco use, and high alcohol consumption) and a general lack of information regarding the relationship between these behaviors and conditions such as obesity, diabetes, and heart disease. Also, the prevalence of cancer and diabetes are rising among the Brazilian population. As per the IDF South and Central America, in 2017, there were more than 12,465,800 cases of diabetes in Brazil. The increasing incidence of diabetes is also expected to hamper the quality of life of patients suffering from diabetes. Thus, the rising burden of chronic diseases increases the demands for the medical admissions, leading to rise in demand for medical headwalls.
As of January 2021, 2020, Brazil has reported 8,195,637 COVID-19 cases, while Argentina has recorded 1,744,704 cases. Deaths reported in Brazil were 204,726, and in Argentina, the death toll was 44,848. For instance, in May 2020, with the COVID-19 cases crossing the millions mark in Brazil, the Brazilian hospitals are struggling to manage the influx of COVID-19 patients; the government has decided to increase the hospital and bed counts to meet the demand of patients. They have responded to the situation by closing borders, ordering quarantines, and imposing a host of restrictions to keep people confined at home. The increase in hospitalization among the pandemic is boosting the growth of the medical headwalls market in South and Central America.
Based on product, the South and Central America medical headwalls market is segmented into horizontal and vertical. The horizontal segment held a larger share of the market in 2019 and is anticipated to register a higher CAGR in the market during the forecast period.
Based on application, the South and Central America medical headwalls market is segmented into the intensive care unit (ICU) / critical care unit (CCU), post-anaesthesia care unit (PACU), patient rooms, and others. The ICU/CCU segment held the largest share of the market in 2019, whereas the patient rooms segment is anticipated to register the highest CAGR in the market during the forecast period.
A few of the major primary and secondary sources referred to while preparing the report on the medical headwalls market are the Cardiovascular Risk Factor Multiple Evaluation (CARMELA) and World Bank.